Pathology
 |
|
7 december 2022 16:24:33 |
| Regulation of Adropin by Sitagliptin monotherapy in participants with newly diagnosed type 2 Diabetes (BMC Endocrine Disorders) |
|
Tweet Adropin is a potent metabolic regulator of insulin sensitivity and glycolipid metabolism. The present study investigated the effects of sitagliptin on adropin and metabolic parameters in participants with newl... |
| 96 viewsCategory: Pathology |
 The short-term outcomes of cementless stem for hip arthroplasty in the elderly patients: comparison with patients  (BMC Musculoskeletal Disorders)People with diabetes adherence to drug, dietary, and lifestyle changes in Erbil city, Iraq (BMC Endocrine Disorders) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
